This page shows the latest haematological cancer news and features for those working in and with pharma, biotech and healthcare.
It was the first green light for the drug in a haematological cancer, and Keytruda has since gone on to receive approval in primary mediastinal B-cell lymphoma, a rare form ... Patients with classical Hodgkin lymphoma are generally young and when they do
broad range of haematological cancer indications.
range of haematological cancer indications.
That mechanism suggests PRM-151 could have potential in a range of diseases characterised by fibrosis, including myelofibrosis – a haematological cancer that results in scarring of the bone marrow and severe ... With our proven track record in IPF with
blockbuster product with sales of $3.6bn in 2018 and a target of $4.4bn this year across a broad range of haematological cancer indications.
and downgraded sales estimates for its haematological cancer drugs.
More from news
Approximately 2 fully matching, plus 35 partially matching documents found.
Janssen granted Tracon Pharmaceuticals the rights to develop two oncology programmes for prostate cancer and haematological malignancies. ... Adaptimmune Therapeutics entered into a collaboration with MD Anderson Cancer Center to develop specific
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...